Association Between Obesity and Malignant Progression of Barrett’s Esophagus

Recent evidence highlights a significant relationship between obesity and the malignant progression of Barrett’s esophagus (BE), specifically towards high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC). This systematic review and meta-analysis examined 20 studies involving over 38,500 patients, aiming to determine whether increased body mass index (BMI) correlates with a heightened risk of developing HGD or EAC in BE patients. The findings provide important implications for risk stratification and clinical management of BE patients.

Key Findings:

1. Dose-Response Relationship: The analysis found a dose-response association between obesity and the progression of BE. Each 5 kg/m² increase in BMI was associated with a 6% increased risk of malignant progression (adjusted odds ratio [OR] 1.06, 95% confidence interval [CI] 1.02-1.10). This highlights the potential role of obesity as a modifiable risk factor in BE management.
2. Impact on Clinical Practice: Given the relationship between BMI and progression to cancer, incorporating weight management strategies could potentially improve patient outcomes. Obesity has been implicated not only as a risk factor for BE but also in the progression from non-dysplastic BE to EAC. Clinicians should consider weight reduction and lifestyle modifications as part of a comprehensive strategy to lower cancer risks in BE patients.
3. Gender and Progression Rates: Data indicated no significant difference in the progression rate between males and females. However, obesity appears to have an equal impact on both genders regarding the likelihood of progression from BE to cancer.
4. Underlying Mechanisms: Several mechanisms might explain the connection between obesity and cancer progression, including increased gastroesophageal reflux, chronic inflammation, and hormonal changes linked to visceral adiposity. These mechanisms may promote the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
5. Clinical Implications and Future Research: This study suggests that obesity should be considered in risk prediction models for patients with BE. Surveillance strategies might be refined to target patients with higher BMI for more frequent monitoring. Future research should explore the effect of central obesity and other metabolic factors beyond BMI to better understand their roles in BE progression.

These findings underscore the importance of addressing obesity in the prevention and management of esophageal cancer. By adopting targeted weight management programs, clinicians can help reduce the overall risk of malignancy in patients with BE, potentially altering the natural course of this pre-cancerous condition.

For further details, the full study can be accessed via the following DOI: https://doi.org/10.1016/j.cgh.2024.07.041.